selected publications
- Distinct mesenchymal cell states mediate prostate cancer progression. bioRxiv : the preprint server for biology. 2023 Article GET IT
- Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol. Critical reviews in oncology/hematology. 2023 Review GET IT
- Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. Therapeutic advances in medical oncology. 2023 Academic Article GET IT
- Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. Journal of translational medicine. 2023 Academic Article GET IT
-
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Nature communications.
2023
Academic Article
GET IT
Times cited: 1 -
Germline variants associated with toxicity to immune checkpoint blockade.
Nature medicine.
2022
Academic Article
GET IT
Times cited: 10 - "Stromal cells in prostate cancer pathobiology: friends or foes?". British journal of cancer. 2022 Review GET IT
-
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.
Cancer cell.
2022
Academic Article
GET IT
Times cited: 14 -
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine.
Cancers.
2022
Review
GET IT
Times cited: 8 -
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
Clinical genitourinary cancer.
2022
Academic Article
GET IT
Times cited: 1 -
Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors.
Clinical genitourinary cancer.
2022
Academic Article
GET IT
Times cited: 4 -
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2022
Academic Article
GET IT
Times cited: 13 -
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer.
Expert review of molecular diagnostics.
2021
Review
GET IT
Times cited: 9 -
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Lung cancer (Amsterdam, Netherlands).
2021
Academic Article
GET IT
Times cited: 5 -
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
JAMA network open.
2021
Academic Article
GET IT
Times cited: 8 -
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2021
Academic Article
GET IT
Times cited: 25 -
Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma.
Clinical genitourinary cancer.
2021
Academic Article
GET IT
Times cited: 7 -
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
Nature communications.
2021
Academic Article
GET IT
Times cited: 57 -
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
Cancer cell.
2020
Letter
GET IT
Times cited: 38 -
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Nature medicine.
2020
Article
GET IT
Times cited: 4 -
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma.
European journal of cancer (Oxford, England : 1990).
2020
Academic Article
GET IT
Times cited: 35 -
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Nature medicine.
2020
Academic Article
GET IT
Times cited: 110 -
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.
Genetics in medicine : official journal of the American College of Medical Genetics.
2020
Academic Article
GET IT
Times cited: 26 -
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 39 -
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 9 -
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 14 -
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 55 -
Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma.
Genetics in medicine : official journal of the American College of Medical Genetics.
2019
Academic Article
GET IT
Times cited: 33 -
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.
Molecular cancer therapeutics.
2019
Academic Article
GET IT
Times cited: 10 -
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
Clinical genitourinary cancer.
2018
Academic Article
GET IT
Times cited: 8 -
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.
Cell.
2018
Academic Article
GET IT
Times cited: 171 -
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.
Oncotarget.
2017
Review
GET IT
Times cited: 57 -
The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
BMC cancer.
2016
Academic Article
GET IT
Times cited: 27 -
Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa).
International journal of molecular sciences.
2015
Academic Article
GET IT
Times cited: 25 -
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report.
2015
GET IT
Times cited: 3 -
Very late recurrence of renal cell carcinoma experiencing long-term response to sunitinib: a case report.
2015
GET IT
Times cited: 3 -
Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery.
International journal of cancer.
2015
Academic Article
GET IT
Times cited: 14 -
Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature.
BMC cancer.
2014
Review
GET IT
Times cited: 4 -
Periostin: a novel prognostic and therapeutic target for genitourinary cancer?.
Clinical genitourinary cancer.
2014
Review
GET IT
Times cited: 41 -
Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines.
Anticancer research.
2013
Academic Article
GET IT
Times cited: 4 -
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death.
BMC cancer.
2012
Academic Article
GET IT
Times cited: 35 -
Prognostic value of nuclear matrix protein expression in localized prostate cancer.
Journal of cancer research and clinical oncology.
2012
Academic Article
GET IT
Times cited: 7